LLY.SW
Eli Lilly and Company
SwissCHFEQUITY
Healthcare
DELAYED
Last price
1,000.00
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
1,000.00
Day high
1,000.00
Day low
1,000.00
Volume
3
Market cap
$891.36B
P/E (TTM)
42.12
52W range
565.00 – 1,010.00
Trailing performance
Returnvs SPY
1W
+1.00%
+2.4%
1M
+4.66%
+0.9%
3M
+19.53%
+16.4%
6M
+27.85%
+16.8%
YTD
+18.82%
+6.5%
1Y
+26.25%
+6.3%
3Y
+130.59%
+56.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on LLY.SW open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.39M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 26 | SULZBERGER GABRIELLE Director |
STOCK | 4 | $4.96K | Direct |
| Aug 17, 26 | JONSSON PATRIK Officer |
SELL | 6.50K | $7.64M | Direct |
| Aug 17, 26 | LUCIANO JUAN R Director |
STOCK | 13 | $15.92K | Direct |
| Aug 17, 26 | ALVAREZ RALPH Director |
STOCK | 10 | $12.42K | Direct |
| Aug 17, 26 | FYRWALD J. ERIK Director |
STOCK | 8 | $9.92K | Direct |
| Aug 10, 26 | ZAKROWSKI DONALD A Officer |
SELL | 2.00K | $2.37M | Direct |
| Aug 7, 26 | HAKIM ANAT General Counsel |
SELL | 5.00K | $5.95M | Indirect |
| Jul 31, 26 | SEYMOUR MELISSA Officer |
— | 981 | — | Direct |
| Jul 20, 26 | SULZBERGER GABRIELLE Director |
STOCK | 4 | $4.96K | Direct |
| Jul 20, 26 | LUCIANO JUAN R Director |
STOCK | 13 | $15.92K | Direct |
| Jul 20, 26 | ALVAREZ RALPH Director |
STOCK | 10 | $12.42K | Direct |
| Jul 20, 26 | FYRWALD J. ERIK Director |
STOCK | 8 | $9.92K | Direct |
| Jun 15, 26 | SULZBERGER GABRIELLE Director |
STOCK | 4 | $4.96K | Direct |
| Jun 15, 26 | LUCIANO JUAN R Director |
STOCK | 14 | $15.92K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ALVAREZ RALPH |
Director | 56.50K | Stock Award(Grant) |
FYRWALD J. ERIK |
Director | 75.42K | Stock Award(Grant) |
HAKIM ANAT |
General Counsel | — | Sale |
HERNANDEZ EDGARDO |
Officer | 46.97K | Stock Award(Grant) |
JONSSON PATRIK |
Officer | 54.78K | Sale |
LILLY ENDOWMENT, INC. |
Beneficial Owner of more than 10% of a Class of Security | 91.88M | Sale |
RICKS DAVID A |
Chief Executive Officer | 708.78K | Stock Award(Grant) |
SKOVRONSKY DANIEL |
Officer | 235.69K | Stock Award(Grant) |
VAN NAARDEN JACOB S. |
Officer | 36.27K | Stock Award(Grant) |
WHITE ANNE E |
President | 74.21K | Stock Award(Grant) |
Fundamentals
Market cap$891.36B
Enterprise value$946.23B
Revenue (TTM)$79.67B
Gross profit$66.44B
EBITDA$41.71B
Net income$26.71B
EPS (TTM)$23.74
Free cash flow$11.07B
Total cash$8.95B
Total debt$54.91B
Book value / share$30.93
Shares outstanding891.36M
Float888.95M
Short % of float—
Dividend yield0.56%
Beta (5Y)0.51
Valuation & profitability ratios
Trailing P/E42.12
Forward P/E—
PEG ratio1.59
Price / sales—
Price / book32.33
EV / revenue11.88
EV / EBITDA22.69
Gross margin83.40%
Operating margin54.22%
Profit margin33.53%
Return on equity102.29%
Return on assets20.36%
Debt / equity162.07
Current ratio1.36
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $65.18B | $45.04B | $34.12B | $28.54B | — | +44.7% |
| Operating revenue | $65.18B | $45.04B | $34.12B | $28.54B | — | +44.7% |
| Cost of revenue | $11.05B | $8.42B | $7.08B | $6.63B | — | +31.3% |
| Gross profit | $54.13B | $36.63B | $27.04B | $21.91B | — | +47.8% |
| Research & development | $13.34B | $10.99B | $9.31B | $7.19B | — | +21.3% |
| Selling, general & admin | $11.09B | $8.59B | $7.40B | $6.44B | — | +29.1% |
| Total operating expense | $24.43B | $19.59B | $16.72B | $13.63B | — | +24.7% |
| Operating income | $29.70B | $17.04B | $10.32B | $8.28B | — | +74.3% |
| Net interest income | — | -$605.40M | -$312.30M | -$268.80M | -$314.40M | — |
| Pre-tax income | $25.73B | $12.68B | $6.55B | $6.81B | — | +102.9% |
| Tax provision | $5.09B | $2.09B | $1.31B | $561.60M | — | +143.6% |
| Net income | $20.64B | $10.59B | $5.24B | $6.24B | — | +94.9% |
| Net income to common | $20.64B | $10.59B | $5.24B | $6.24B | — | +94.9% |
| Basic EPS | 23.00 | 11.80 | 5.83 | 6.57 | — | +94.9% |
| Diluted EPS | 22.95 | 11.71 | 5.80 | 6.57 | — | +96.0% |
| EBIT | $29.70B | $17.04B | $10.32B | $7.14B | — | +74.3% |
| EBITDA | $31.69B | $18.81B | $11.85B | $8.66B | — | +68.5% |
| Basic shares | 897.30M | 897.54M | 899.38M | 950.18M | — | -0.0% |
| Diluted shares | 899.30M | 904.06M | 903.28M | 950.18M | — | -0.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $7.27B | $3.27B | $2.82B | $2.07B | +122.4% |
| Cash & short-term investments | $7.27B | $3.27B | $2.93B | $2.21B | +122.4% |
| Accounts receivable | $17.76B | $11.01B | $9.09B | $6.90B | +61.4% |
| Inventory | $13.74B | $7.59B | $5.77B | $4.31B | +81.1% |
| Total current assets | $55.63B | $32.74B | $25.73B | $18.03B | +69.9% |
| Property, plant & equipment | $24.67B | $17.10B | $12.91B | $10.14B | +44.3% |
| Goodwill & intangibles | $12.42B | $11.94B | $11.85B | $11.28B | +4.1% |
| Total assets | $112.48B | $78.72B | $64.01B | $49.49B | +42.9% |
| Total current liabilities | $35.23B | $28.38B | $27.29B | $17.14B | +24.1% |
| Current debt | $1.64B | $5.12B | $6.90B | $1.50B | -68.0% |
| Long-term debt | $40.87B | $28.53B | $18.32B | $14.74B | +43.3% |
| Total debt | $42.50B | $33.64B | $25.23B | $16.24B | +26.3% |
| Total liabilities | $85.94B | $64.44B | $53.14B | $38.71B | +33.4% |
| Retained earnings | $24.47B | $13.54B | $10.31B | $10.04B | +80.7% |
| Shareholder equity | $26.54B | $14.27B | $10.77B | $10.65B | +85.9% |
| Working capital | $20.40B | $4.36B | -$1.57B | $896.30M | +367.5% |
| Net tangible assets | $14.12B | $2.34B | -$1.07B | -$629.80M | +504.2% |
| Shares issued | 944.80M | 947.90M | 949.78M | 950.63M | -0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $20.64B | $10.59B | $5.24B | $6.24B | +94.9% |
| Depreciation & amortisation | $2.00B | $1.77B | $1.53B | $1.52B | +13.0% |
| Stock-based compensation | $626.00M | $646.00M | $629.00M | $371.10M | -3.1% |
| Change in working capital | -$8.09B | -$5.38B | -$3.06B | -$800.00K | -50.3% |
| Operating cash flow | $16.81B | $8.82B | $4.24B | $7.59B | +90.7% |
| Capital expenditure | -$10.85B | -$8.40B | -$7.39B | -$2.99B | -29.1% |
| Investing cash flow | -$10.97B | -$9.30B | -$7.15B | -$3.76B | -18.0% |
| Share buybacks | -$4.11B | -$2.50B | -$750.00M | -$1.50B | -64.3% |
| Dividends paid | -$5.38B | -$4.68B | -$4.07B | -$3.54B | -15.0% |
| Financing cash flow | -$2.21B | $1.23B | $3.50B | -$5.41B | -279.9% |
| Free cash flow | $5.96B | $414.00M | -$3.15B | $4.60B | +1,340.6% |
| End cash position | $7.27B | $3.27B | $2.82B | $2.07B | +122.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $22.97B | $19.80B | $19.29B | $17.60B | $15.56B | — | +16.0% |
| Operating revenue | $22.97B | $19.80B | $19.29B | $17.60B | $15.56B | — | +16.0% |
| Cost of revenue | $3.27B | $3.58B | $3.37B | $3.01B | $2.45B | — | -8.6% |
| Gross profit | $19.71B | $16.22B | $15.92B | $14.59B | $13.11B | — | +21.5% |
| Research & development | $3.82B | $3.51B | $3.80B | $3.47B | $3.34B | — | +8.8% |
| Selling, general & admin | $3.43B | $2.93B | $3.13B | $2.74B | $2.75B | — | +16.9% |
| Total operating expense | $7.25B | $6.44B | $6.93B | $6.21B | $6.09B | — | +12.5% |
| Operating income | $12.46B | $9.78B | $8.99B | $8.39B | $7.02B | — | +27.4% |
| Net interest income | — | — | — | -$114.60M | -$209.00M | -$195.40M | — |
| Pre-tax income | $9.25B | $8.85B | $8.27B | $7.23B | $6.78B | — | +4.5% |
| Tax provision | $2.15B | $1.45B | $1.63B | $1.65B | $1.12B | — | +48.0% |
| Net income | $7.09B | $7.40B | $6.64B | $5.58B | $5.66B | — | -4.1% |
| Net income to common | $7.09B | $7.40B | $6.64B | $5.58B | $5.66B | — | -4.1% |
| Basic EPS | 7.96 | 8.28 | 7.42 | 6.22 | 6.30 | — | -3.9% |
| Diluted EPS | 7.94 | 8.26 | 7.39 | — | 6.29 | 3.06 | -3.9% |
| EBIT | $12.46B | $9.78B | $11.56B | $7.41B | $7.02B | — | +27.4% |
| EBITDA | $12.99B | $10.29B | $12.14B | $7.88B | $7.50B | — | +26.3% |
| Basic shares | 891.50M | 893.50M | 894.80M | 896.90M | 897.90M | — | -0.2% |
| Diluted shares | 893.67M | 895.92M | 898.00M | 898.80M | 899.80M | — | -0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.95B | $5.28B | $7.27B | $9.79B | $3.38B | +69.4% |
| Cash & short-term investments | $8.95B | $5.28B | $7.27B | $9.91B | $3.55B | +69.4% |
| Accounts receivable | $20.08B | $18.43B | $17.76B | $16.11B | $14.17B | +9.0% |
| Inventory | $16.79B | $14.53B | $13.74B | $12.18B | $11.01B | +15.6% |
| Total current assets | $64.67B | $54.84B | $55.63B | $62.07B | $49.85B | +17.9% |
| Property, plant & equipment | $29.29B | $26.54B | $24.67B | $22.32B | $20.53B | +10.3% |
| Goodwill & intangibles | $26.96B | $13.50B | $12.42B | $12.34B | $11.68B | +99.6% |
| Total assets | $142.28B | $116.58B | $112.48B | $114.94B | $100.92B | +22.1% |
| Total current liabilities | $47.74B | $36.63B | $35.23B | $40.14B | $39.02B | +30.3% |
| Current debt | $7.05B | $4.00B | $1.64B | $1.63B | $5.72B | +76.3% |
| Long-term debt | $47.86B | $39.37B | $40.87B | $40.87B | $34.18B | +21.6% |
| Total debt | $54.91B | $43.37B | $42.50B | $42.51B | $39.90B | +26.6% |
| Total liabilities | $108.40B | $85.38B | $85.94B | $91.08B | $82.57B | +27.0% |
| Retained earnings | $31.89B | $29.51B | $24.47B | $22.25B | $17.38B | +8.1% |
| Shareholder equity | $33.88B | $31.20B | $26.54B | $23.79B | $18.27B | +8.6% |
| Working capital | $16.93B | $18.20B | $20.40B | $21.93B | $10.83B | -7.0% |
| Net tangible assets | $6.92B | $17.69B | $14.12B | $11.45B | $6.59B | -60.9% |
| Shares issued | 891.50M | 943.50M | 944.80M | 946.21M | 947.20M | -5.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $7.09B | $7.40B | $6.64B | $5.58B | $5.66B | -4.1% |
| Depreciation & amortisation | $534.00M | $509.00M | $585.70M | $470.30M | $478.00M | +4.9% |
| Stock-based compensation | $201.00M | $161.00M | $136.10M | $150.90M | $185.00M | +24.8% |
| Change in working capital | -$670.00M | -$1.66B | -$3.67B | $1.21B | -$2.26B | +59.7% |
| Operating cash flow | $10.69B | $5.33B | $3.22B | $8.84B | $3.09B | +100.5% |
| Capital expenditure | -$6.21B | -$2.53B | -$2.97B | -$2.81B | -$1.80B | -145.7% |
| Investing cash flow | -$15.40B | -$3.92B | -$2.80B | -$2.98B | -$1.83B | -293.2% |
| Share buybacks | -$1.60B | -$2.36B | -$1.51B | -$708.30M | -$692.00M | +32.0% |
| Dividends paid | -$1.55B | -$1.55B | -$1.35B | -$1.35B | -$1.35B | +0.1% |
| Financing cash flow | $8.43B | -$3.47B | -$2.88B | $530.80M | -$1.25B | +342.8% |
| Free cash flow | $4.47B | $2.80B | $254.20M | $6.03B | $1.28B | +59.7% |
| End cash position | $8.95B | $5.28B | $7.27B | $9.79B | $3.38B | +69.4% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $22.23B | +26.3% |
| Next quarter | — | — | $23.21B | +20.3% |
| Current year | — | — | $88.18B | +35.3% |
| Next year | — | — | $101.75B | +15.4% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.16%
Held by institutions85.41%
Institutions holding5.86K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
988.00
+1.21% from price
SMA 20
969.25
+4.20% from price
SMA 50
951.80
+6.11% from price
SMA 100
867.20
+15.31% from price
SMA 200
838.18
+20.50% from price
EMA 12
985.07
+1.52% from price
EMA 26
969.31
+3.17% from price
EMA 50
943.48
+5.99% from price
RSI (14)
63.0
Neutral
MACD (12,26,9)
15.76
Hist 4.10
ATR (14)
11.79
1.17% of price
Realised vol 30D
34.0%
Annualised
Bollinger upper
1,036.28
20, 2σ
Bollinger lower
902.22
20, 2σ
50 / 200 cross
Golden
951.80 vs 838.18
Trend bias
Above 200
+20.50%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.18
Less volatile than market
Correlation to SPY
0.06
Largely independent
Realised vol 30D
34.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-24.4%
Peak to trough
Max drawdown 5Y
-34.9%
Peak to trough
ATR 14
11.79
1.17% of price
Beta (reported)
0.51
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 6, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Aug 6, 26 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Jul 15, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Jul 14, 26 | Bernstein | MAINTAINED | Outperform | Outperform |
| Jul 13, 26 | UBS | MAINTAINED | Buy | Buy |
| Jul 13, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 10, 26 | B of A Securities | MAINTAINED | Buy | Buy |
| Jul 8, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 8, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jul 8, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 7, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate$5.63 / yr
Forward yield0.56%
5-year avg yield0.88%
Payout ratio21.69%
Ex-dividend dateAug 14, 2026
Next pay dateJun 10, 2025
Last split—
Split date—
Headlines
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Motley Fool · 4m ago
Uber faces fine of nearly $1B over automated driver suspensions
TechCrunch · 14m ago
This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It.
Motley Fool · 16m ago
This Chinese Tech Giant Quietly Cut Its Buyback 80% to Fund AI
24/7 Wall St. · 26m ago
Look Back: Long before Party on the Patio, Mötley Crüe rocked Pocono Downs
The Times-Leader (Wilkes-Barre, Pa.) · 27m ago
Prediction: ExxonMobil Raises Its Dividend More Than Wall Street Expects
Motley Fool · 28m ago
Amazon is selling Nothing noise-canceling earbuds for $59, and they 'stay in place comfortably for hours'
TheStreet · 29m ago
Linkdaze’s smart calendar is built to run a household, not just track a schedule
TechCrunch · 30m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.